latest news releases from the newsroom
Generex Biotechnology Corp.
Generex Scientist to Participate in Panel Discussion At Swine Influenza Symposium
WORCESTER, Mass., May 28, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. (www.antigenexpress.com), Generex's wholly-owned immunotherapeutics subsidiary, will participate in a panel discussion this afternoon at the Human Swine Flu (H1N1) and Novel Influenza Pandemics symposium being hosted by The New York Academy of Sciences (NYAS) to be held at the NYAS conference center in New York City. The symposium will feature presentations by leaders in the field and will explore the latest swine influenza (H1N1 flu) outbreak with talks on the new reassortant virus, epidemiology, vaccines, treatment, and public health aspects.
CDMA Development Group
CDMA is Now Being Used by More Than 100 Million People in India
MUMBAI, India, May 28, 2009 (GLOBE NEWSWIRE) -- The CDMA Development Group (CDG) (www.cdg.org) today announced that there are now more than 100 million CDMA subscribers in India, making it the world's second-largest CDMA market. Reliance Communications and Tata Teleservices are placed among the top five CDMA operators globally, ranking second and fourth, respectively. The rapid growth of CDMA users in India is attributed to a wide selection of affordable devices - ranging from entry level handsets to feature-rich smartphones - and the introduction of CDMA2000(r) voice and data services into urban and rural areas, helping to reshape the communications culture of India.